Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Michelle Pearlman, MD

Advertisement

Articles by Michelle Pearlman, MD

Drs. Amy and Michelle Pearlman provide an overview of their practice, Prime Institute

ByAmy M. Pearlman, MD,Michelle Pearlman, MD
November 10th 2025

Sisters Amy Pearlman, MD, and Michelle Pearlman, MD, provide an overview of their shared practice, Prime Institute.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Urology Times

    1

    FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures

    2

    Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study

    3

    Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC

    4

    Michael Cookson, MD, discusses new strategies for treatment intensification in prostate cancer

    5

    Qualitative data show high usability of gemcitabine intravesical system

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Job Board
    • Terms and Conditions
    • Privacy
    • Do not sell my Personnal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us